A5029386152- Mosquito-borne diseases and control
- Malaria Research and Control
- Viral Infections and Vectors
- Multiple Sclerosis Research Studies
- Antiplatelet Therapy and Cardiovascular Diseases
- Immunotherapy and Immune Responses
- Monoclonal and Polyclonal Antibodies Research
- Insect symbiosis and bacterial influences
- Cancer Immunotherapy and Biomarkers
- COVID-19 Clinical Research Studies
Janssen (United States)
2022
Rocky Mountain MS Center
2019
Colorado State University
2016
Background Epidemic dengue fever (DF) and hemorrhagic fever/dengue shock syndrome (DHF/DSS) are overwhelming public health capacity for diagnosis clinical care of patients throughout the tropical subtropical world. The ability to predict severe disease outcomes using acute phase specimens would be enormous value physicians workers appropriate triaging management. Advances in field metabolomics analytic software provide new opportunities identify host small molecule biomarkers (SMBs) that...
Epidemic dengue has emerged throughout the tropical world. In continued absence of a vaccine against virus (DENV), mosquito vector surveillance and control programs are essential to reduce human infections. An effective test detect DENV in infected mosquitoes would be valuable addition effort. We investigated detection Aedes aegypti using commercially available non-structural protein 1 (NS1) ELISA kit (Platelia Dengue NS1 Ag), by reverse transcription-polymerase chain reaction (RT-PCR)...